Interplay of Cardiovascular Health and Diabetes: Insights into Weight Management and Risk Reduction

Overview

Journal J Diabetes Investig

Specialty Endocrinology

Date 2024 Feb 23

PMID 38389209

Authors

Chih-Yao Hsu

Hung-Yuan Li

Affiliations

Soon will be listed here.

References

Yoshimura R, Nakagami T, Hasegawa Y, Oya J, Babazono T . Association between changes in bodyweight and cardiovascular disease risk factors among obese Japanese patients with type 2 diabetes. J Diabetes Investig. 2022; 13(9):1560-1566. PMC: 9434567. DOI: 10.1111/jdi.13809. View

Kim D, Sheu W, Chung W, Yabe D, Ha K, Nangaku M . Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study. J Diabetes Investig. 2023; 14(3):417-428. PMC: 9951576. DOI: 10.1111/jdi.13959. View

Kashiwagi A, Shoji S, Onozawa S, Kosakai Y, Waratani M, Ito Y . Reduction in cardiovascular disease events in patients with type 2 diabetes mellitus treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: A real-world retrospective administrative database analysis in.... J Diabetes Investig. 2022; 13(7):1175-1189. PMC: 9248422. DOI: 10.1111/jdi.13785. View

Kashiwagi A, Shoji S, Kosakai Y, Koga T, Asakawa K, Rokuda M . Cardiometabolic risk reductions in patients with type 2 diabetes mellitus newly treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: A real-world administrative database study in Japan. J Diabetes Investig. 2022; 14(3):404-416. PMC: 9951561. DOI: 10.1111/jdi.13952. View

Okada A, Kaneko H, Matsuoka S, Itoh H, Suzuki Y, Fujiu K . Association of cardiovascular health metrics with annual incidence of prediabetes or diabetes: Analysis of a nationwide real-world database. J Diabetes Investig. 2022; 14(3):452-462. PMC: 9951564. DOI: 10.1111/jdi.13958. View

Cox B, Luyten L, Dockx Y, Provost E, Madhloum N, De Boever P . Association Between Maternal Prepregnancy Body Mass Index and Anthropometric Parameters, Blood Pressure, and Retinal Microvasculature in Children Age 4 to 6 Years. JAMA Netw Open. 2020; 3(5):e204662. PMC: 7218490. DOI: 10.1001/jamanetworkopen.2020.4662. View

Yagyu H, Shimano H . Treatment of diabetes mellitus has borne much fruit in the prevention of cardiovascular disease. J Diabetes Investig. 2022; 13(9):1472-1488. PMC: 9434581. DOI: 10.1111/jdi.13859. View

Bouchi R, Kondo T, Ohta Y, Goto A, Tanaka D, Satoh H . A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes. J Diabetes Investig. 2022; 14(1):151-164. PMC: 9807160. DOI: 10.1111/jdi.13960. View

Ishii H . Cardiovascular events and atherosclerosis in patients with type 2 diabetes and impaired glucose tolerance: What are the medical treatments to prevent cardiovascular events in such patients?. J Diabetes Investig. 2022; 13(7):1114-1121. PMC: 9248425. DOI: 10.1111/jdi.13799. View

10.

Kee O, Harun H, Mustafa N, Abdul Murad N, Chin S, Jaafar R . Cardiovascular complications in a diabetes prediction model using machine learning: a systematic review. Cardiovasc Diabetol. 2023; 22(1):13. PMC: 9854013. DOI: 10.1186/s12933-023-01741-7. View

11.

Wing R, Bolin P, Brancati F, Bray G, Clark J, Coday M . Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013; 369(2):145-54. PMC: 3791615. DOI: 10.1056/NEJMoa1212914. View

12.

Gregg E, Jakicic J, Blackburn G, Bloomquist P, Bray G, Clark J . Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016; 4(11):913-921. PMC: 5094846. DOI: 10.1016/S2213-8587(16)30162-0. View

13.

Zhang Z, Zhou Z, Li H . The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis. J Diabetes Investig. 2023; 15(1):15-25. PMC: 10759727. DOI: 10.1111/jdi.14119. View

14.

Eriksson U, Cederberg J, Wentzel P . Congenital malformations in offspring of diabetic mothers--animal and human studies. Rev Endocr Metab Disord. 2003; 4(1):79-93. DOI: 10.1023/a:1021879504372. View

15.

Razaz N, Villamor E, Muraca G, Edstedt Bonamy A, Cnattingius S . Maternal obesity and risk of cardiovascular diseases in offspring: a population-based cohort and sibling-controlled study. Lancet Diabetes Endocrinol. 2020; 8(7):572-581. DOI: 10.1016/S2213-8587(20)30151-0. View

16.

Wu X, Ge R, Huang L, Tian F, Chen Y, Wu L . Pregestational diabetes mediates the association between maternal obesity and the risk of congenital heart defects. J Diabetes Investig. 2021; 13(2):367-374. PMC: 8847144. DOI: 10.1111/jdi.13666. View

17.

Asgari S, Masrouri S, Hosseinpour-Niazi S, Moslehi N, Azizi F, Hadaegh F . Association of ideal cardiovascular health metrics and incident type 2 diabetes mellitus among an urban population of Iran: One decade follow up in the Tehran Lipid and Glucose Study. J Diabetes Investig. 2022; 13(10):1711-1722. PMC: 9533049. DOI: 10.1111/jdi.13839. View

18.

Chai Y, Liu Y, Yang R, Kuang M, Qiu J, Zou Y . Association of body mass index with risk of prediabetes in Chinese adults: A population-based cohort study. J Diabetes Investig. 2022; 13(7):1235-1244. PMC: 9248430. DOI: 10.1111/jdi.13783. View

19.

Seino Y, Kim D, Yabe D, Tan E, Chung W, Ha K . Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study. Endocrinol Diabetes Metab. 2021; 4(1):e00183. PMC: 7831226. DOI: 10.1002/edm2.183. View

20.

Zhong X, Xu X, Liu M, Wang P, He L, Christopher O . Effect of intensive lifestyle intervention on the association between weight variability and major adverse cardiovascular events in overweight or obese adults with type 2 diabetes mellitus. J Diabetes Investig. 2023; 14(3):441-451. PMC: 9951560. DOI: 10.1111/jdi.13964. View